Pol Andrés‐Benito

1.9k total citations
62 papers, 1.2k citations indexed

About

Pol Andrés‐Benito is a scholar working on Molecular Biology, Physiology and Neurology. According to data from OpenAlex, Pol Andrés‐Benito has authored 62 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 29 papers in Physiology and 27 papers in Neurology. Recurrent topics in Pol Andrés‐Benito's work include Alzheimer's disease research and treatments (28 papers), Amyotrophic Lateral Sclerosis Research (20 papers) and Parkinson's Disease Mechanisms and Treatments (12 papers). Pol Andrés‐Benito is often cited by papers focused on Alzheimer's disease research and treatments (28 papers), Amyotrophic Lateral Sclerosis Research (20 papers) and Parkinson's Disease Mechanisms and Treatments (12 papers). Pol Andrés‐Benito collaborates with scholars based in Spain, United States and Austria. Pol Andrés‐Benito's co-authors include Isidró Ferrer, Ester Aso, Margarita Carmona, Mónica Povedano, José Antonio del Rı́o, Benjamı́n Torrejón-Escribano, Enrique Santamaría, Joaquín Fernández‐Irigoyen, Paula Garcia‐Esparcia and Raúl Domínguez and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Pol Andrés‐Benito

60 papers receiving 1.2k citations

Peers

Pol Andrés‐Benito
Pol Andrés‐Benito
Citations per year, relative to Pol Andrés‐Benito Pol Andrés‐Benito (= 1×) peers Hiroki Sasaguri

Countries citing papers authored by Pol Andrés‐Benito

Since Specialization
Citations

This map shows the geographic impact of Pol Andrés‐Benito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pol Andrés‐Benito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pol Andrés‐Benito more than expected).

Fields of papers citing papers by Pol Andrés‐Benito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pol Andrés‐Benito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pol Andrés‐Benito. The network helps show where Pol Andrés‐Benito may publish in the future.

Co-authorship network of co-authors of Pol Andrés‐Benito

This figure shows the co-authorship network connecting the top 25 collaborators of Pol Andrés‐Benito. A scholar is included among the top collaborators of Pol Andrés‐Benito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pol Andrés‐Benito. Pol Andrés‐Benito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ayala, Victòria, Mónica Povedano, Pol Andrés‐Benito, et al.. (2025). Microbial Influences on Amyotrophic Lateral Sclerosis: The Gut–Brain Axis and Therapeutic Potential of Microbiota Modulation. SHILAP Revista de lepidopterología. 3(1). 8–8. 3 indexed citations
2.
Ramírez‐Núñez, Omar, Pascual Torres, Victòria Ayala, et al.. (2025). Nuclear pore complex dysfunction drives TDP-43 pathology in ALS. Redox Biology. 86. 103824–103824.
3.
Pons‐Espinal, Meritxell, Irene Fernández‐Carasa, Pol Andrés‐Benito, et al.. (2024). Blocking IL-6 signaling prevents astrocyte-induced neurodegeneration in an iPSC-based model of Parkinson’s disease. JCI Insight. 9(3). 21 indexed citations
4.
Andrés‐Benito, Pol, Juan F. Vázquez‐Costa, M.J. Colomina, et al.. (2024). Neurodegeneration Biomarkers in Adult Spinal Muscular Atrophy (SMA) Patients Treated with Nusinersen. International Journal of Molecular Sciences. 25(7). 3810–3810. 7 indexed citations
5.
López‐Cano, Marc, Víctor Fernández‐Dueñas, Ana B. Muñoz‐Manchado, et al.. (2024). GPR37 processing in neurodegeneration: a potential marker for Parkinson’s Disease progression rate. npj Parkinson s Disease. 10(1). 172–172. 4 indexed citations
6.
Cotrufo, Tiziana, Pol Andrés‐Benito, Eulàlia Martı́, et al.. (2024). miR-519a-3p, found to regulate cellular prion protein during Alzheimer's disease pathogenesis, as a biomarker of asymptomatic stages. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(5). 167187–167187. 1 indexed citations
7.
Santpere, Gabriel, et al.. (2023). Primary Feline Tauopathy: Clinical, Morphological, Immunohistochemical, and Genetic Studies. Animals. 13(18). 2985–2985. 1 indexed citations
8.
Andrés‐Benito, Pol, África Flores, Margarita Carmona, et al.. (2023). Deregulated Transcription and Proteostasis in Adult mapt Knockout Mouse. International Journal of Molecular Sciences. 24(7). 6559–6559. 2 indexed citations
9.
Brewer, M. Kathryn, Pascual Torres, Victòria Ayala, et al.. (2023). Glycogen accumulation modulates life span in a mouse model of amyotrophic lateral sclerosis. Journal of Neurochemistry. 168(5). 744–759. 6 indexed citations
10.
Torres, Pascual, Carlos Anerillas, Omar Ramírez‐Núñez, et al.. (2022). A motor neuron disease mouse model reveals a non-canonical profile of senescence biomarkers. Disease Models & Mechanisms. 15(8). 12 indexed citations
11.
Díez, Ibai, Andone Sistiaga, María Cristina Caballero, et al.. (2021). Transcriptional signatures of synaptic vesicle genes define myotonic dystrophy type I neurodegeneration. Neuropathology and Applied Neurobiology. 47(7). 1092–1108. 12 indexed citations
13.
Andrés‐Benito, Pol, Ellen Gelpí, Mariona Jové, et al.. (2020). Lipid alterations in human frontal cortex in ALS‐FTLD‐TDP43 proteinopathy spectrum are partly related to peroxisome impairment. Neuropathology and Applied Neurobiology. 47(4). 544–563. 15 indexed citations
14.
Santpere, Gabriel, et al.. (2020). The Presence of Human Herpesvirus 6 in the Brain in Health and Disease. Biomolecules. 10(11). 1520–1520. 34 indexed citations
15.
Martínez‐González, Loreto, Carmen Rodríguez‐Cueto, Fernando Benito Bartolomé, et al.. (2020). Motor neuron preservation and decrease of in vivo TDP-43 phosphorylation by protein CK-1δ kinase inhibitor treatment. Scientific Reports. 10(1). 4449–4449. 42 indexed citations
16.
Aso, Ester, Pol Andrés‐Benito, Laura Caltana, et al.. (2019). Cannabidiol-Enriched Extract Reduced the Cognitive Impairment but Not the Epileptic Seizures in a Lafora Disease Animal Model. Cannabis and Cannabinoid Research. 5(2). 150–163. 11 indexed citations
17.
González‐Fernández, Carlos, Pau González, Pol Andrés‐Benito, Isidró Ferrer, & Francisco Javier Rodríguez. (2019). Wnt Signaling Alterations in the Human Spinal Cord of Amyotrophic Lateral Sclerosis Cases: Spotlight on Fz2 and Wnt5a. Molecular Neurobiology. 56(10). 6777–6791. 29 indexed citations
18.
Silva-Abreu, Marcelle, Ana Cristina Calpena, Pol Andrés‐Benito, et al.. (2018). PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer’s disease: in vitro and in vivo studies. International Journal of Nanomedicine. Volume 13. 5577–5590. 64 indexed citations
19.
Llorens, Franc, Katrin Thüne, Pol Andrés‐Benito, et al.. (2017). MicroRNA Expression in the Locus Coeruleus, Entorhinal Cortex, and Hippocampus at Early and Middle Stages of Braak Neurofibrillary Tangle Pathology. Journal of Molecular Neuroscience. 63(2). 206–215. 17 indexed citations
20.
Porquet, David, Pol Andrés‐Benito, Christian Griñán‐Ferré, et al.. (2015). Amyloid and tau pathology of familial Alzheimer’s disease APP/PS1 mouse model in a senescence phenotype background (SAMP8). AGE. 37(1). 9747–9747. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026